Evaluation of the Philips Lifeline CareSage Risk Assessment System

Completed · Not applicable

Conditions studied: Multimorbidity

In brief

This study is being done to evaluate the impact of a system called CareSage. The CareSage system is a technology that uses clinical data to monitor, identify and target care to patients at risk of being transported to the hospital. The investigators want to see whether the CareSage system is effective in helping to identify hospital admissions which can be prevented.

Key facts

Study ID

NCT03126565

Run by

Massachusetts General Hospital

People needed

370

Starts

2017-05-19

Expected to finish

2019-11-30

Last updated by the study team

2020-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• Receiving care from Partners Healthcare at Home (PHH)
• Total healthcare costs fall within the middle 51st-95th percentile of patients seen at Partners Healthcare from fiscal year 2016

You may not qualify if…

• Currently on admission in a hospital facility with planned discharge to a long-term-care facility or Skilled Nursing Facilities (SNFs).
• Severe dementia, Alzheimer's or other serious psychiatric illness (severe anxiety disorder or psychosis).
• Enrolled in the Integrated Care Management Program (iCMP) program.
• Continued telemonitoring (TM) support extending into the 6 months of study period post the observation period of 3 months.
• PHH patients with pacemakers and other implanted devices

Where it is running

• Partners Healthcare at Home — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.